BRD2 and colorectal carcinoma: Although this study is not meant to be a comprehensive view of CRC immunopeptidomics, the primary goal of our work was to provide a proof of concept that aeTSAs can be identified and are more abundantly presented at the cell surface of CRC than of paired NAT.